Welcome to LookChem.com Sign In|Join Free
  • or
"Benzenamine, 4,4'-(2,3-quinoxalinediyl)bis-" is a complex organic compound with the chemical formula C20H16N4. It is a derivative of benzenamine (aniline), featuring a 2,3-quinoxalinediyl bridge connecting two benzenamine units. Benzenamine, 4,4'-(2,3-quinoxalinediyl)bis- is characterized by its aromatic structure and potential applications in various chemical and pharmaceutical processes. Due to its specific molecular structure, it may exhibit unique properties and reactivity, making it a subject of interest for researchers in the field of organic chemistry.

2810-93-7

Post Buying Request

2810-93-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2810-93-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2810-93-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,1 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2810-93:
(6*2)+(5*8)+(4*1)+(3*0)+(2*9)+(1*3)=77
77 % 10 = 7
So 2810-93-7 is a valid CAS Registry Number.

2810-93-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[3-(4-aminophenyl)quinoxalin-2-yl]aniline

1.2 Other means of identification

Product number -
Other names 2,3-Bis(p-aminophenyl)quinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2810-93-7 SDS

2810-93-7Downstream Products

2810-93-7Relevant academic research and scientific papers

Combination therapy

-

, (2008/06/13)

The present invention relates to methods of treating cancer using a combination of at least two Akt inhibitors or a compound which is an inhibitor of Akt and an inhibitor of a protein kinase, which methods comprise administering to a mammal, either sequentially in any order or simultaneously, amounts of at least two therapeutic agents selected from a group consisting of a compound(s) which are inhibitors of Akt and compound(s) which are inhibitors of protein kinases. The invention also relates to methods of preparing such compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2810-93-7